Associate Chief Physician, Master’s Supervisor, Doctor of Clinical Medicine Lead Physician for Specialized Treatment of Cerebral Palsy, Hemiplegia, and Paraplegia Head of the Neurofibromatosis Research Group and Medical Team Leader Hangzhou Children’s Hospital Principal Investigator (PI) for the Sub-center of the Observational Study on the Efficacy and Safety of MEK1/2 Inhibitors (MEKi) in Pediatric Patients with Symptomatic, Inoperable Type 1 Neurofibromatosis (NF1)-Related Plexiform Neurofibromas (PN) (National Multicenter Clinical Study) Principal Investigator (PI) for the Sub-center of the Observational Cohort Study on Disease Burden in Patients with NF1-PN (National Multicenter Clinical Study) With over 15 years of experience in neurosurgery, Dr. Zhang Song specializes in the diagnosis and treatment of common, frequently occurring, and complex neurological disorders. He has extensive clinical expertise in the integrated surgical and rehabilitative management of central limb spasticity (including cerebral palsy, hemiplegia, paraplegia, spinal cord injuries, and sequelae of cerebral hemorrhage and cerebral infarction), as well as in the combined surgical and targeted drug therapy for Type 1 neurofibromatosis. He has diagnosed and treated over 5,000 patients with limb spasticity.